238 related articles for article (PubMed ID: 32707214)
1. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy.
Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214
[TBL] [Abstract][Full Text] [Related]
2. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus.
Rizzo P; Pitocco D; Zaccardi F; Di Stasio E; Strollo R; Rizzi A; Scavone G; Costantini F; Galli M; Tinelli G; Flex A; Caputo S; Pozzilli P; Landolfi R; Ghirlanda G; Nissim A
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27454862
[TBL] [Abstract][Full Text] [Related]
5. Infrared dermal thermometry is highly reliable in the assessment of patients with Charcot neuroarthropathy.
Dallimore SM; Puli N; Kim D; Kaminski MR
J Foot Ankle Res; 2020 Sep; 13(1):56. PubMed ID: 32928270
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
[TBL] [Abstract][Full Text] [Related]
7. The Charcot joint: a modern neurologic perspective.
Chisholm KA; Gilchrist JM
J Clin Neuromuscul Dis; 2011 Sep; 13(1):1-13. PubMed ID: 22361621
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous microvascular reactivity in Charcot neuroarthropathy: a systematic review and meta-analysis.
Lanting SM; Chan TL; Casey SL; Peterson BJ; Chuter VH
J Foot Ankle Res; 2022 Mar; 15(1):17. PubMed ID: 35232466
[TBL] [Abstract][Full Text] [Related]
9. Charcot Pathogenesis: A Study of In Vivo Gene Expression.
Connors JC; Hardy MA; Kishman LL; Botek GG; Verdin CJ; Rao NM; Kingsley JD
J Foot Ankle Surg; 2018; 57(6):1067-1072. PubMed ID: 30368423
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
11. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients.
Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J
Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776
[TBL] [Abstract][Full Text] [Related]
12. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development.
Bruhn-Olszewska B; Korzon-Burakowska A; Węgrzyn G; Jakóbkiewicz-Banecka J
Sci Rep; 2017 Mar; 7(1):501. PubMed ID: 28356555
[TBL] [Abstract][Full Text] [Related]
14. The Diabetic Charcot Foot from 1936 to 2016: Eighty Years Later and Still Growing.
Ramanujam CL; Zgonis T
Clin Podiatr Med Surg; 2017 Jan; 34(1):1-8. PubMed ID: 27865310
[TBL] [Abstract][Full Text] [Related]
15. Role of body mass index in acute charcot neuroarthropathy.
Ross AJ; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
[TBL] [Abstract][Full Text] [Related]
16. Evidence of Autoimmune Involvement in the Pathogenesis of Charcot Neuroarthropathy: A Novel Hypothesis with Preliminary Data.
Verdin CJ; Botek GG; Owings TM; Kingsley JD
J Am Podiatr Med Assoc; 2023; 113(4):. PubMed ID: 37708156
[TBL] [Abstract][Full Text] [Related]
17. Neuroarthropathy in diabetes: pathogenesis of Charcot arthropathy.
Johnson-Lynn SE; McCaskie AW; Coll AP; Robinson AHN
Bone Joint Res; 2018 May; 7(5):373-378. PubMed ID: 29922458
[TBL] [Abstract][Full Text] [Related]
18. The diabetic Charcot foot.
Dissanayake SU; Bowling FL; Jude EB
Curr Diabetes Rev; 2012 May; 8(3):191-4. PubMed ID: 22429012
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?
Selby PL; Young MJ; Boulton AJ
Diabet Med; 1994; 11(1):28-31. PubMed ID: 8181248
[TBL] [Abstract][Full Text] [Related]
20. [Early development of Charcot neuroarthropathy in the course of compensated diabetes mellitus--case report].
Kamińska A; Kamiński M; Jesionka P; Szymkowiak E; Bronisz A; Zmudzińska M; Junik R; Sikorska Z
Pol Arch Med Wewn; 2004 Jun; 111(6):709-13. PubMed ID: 15508794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
